These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11130352)

  • 1. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose?
    Lenton SR; Hargreaves KM
    Med J Aust; 2000 Sep; 173(5):260-3. PubMed ID: 11130352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.
    Coffin PO; Sullivan SD
    Ann Intern Med; 2013 Jan; 158(1):1-9. PubMed ID: 23277895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone for administration by peers in cases of heroin overdose.
    Lenton SR; Dietze PM; Degenhardt L; Darke S; Butler TG
    Med J Aust; 2009 Oct; 191(8):469. PubMed ID: 19835548
    [No Abstract]   [Full Text] [Related]  

  • 4. The distribution of naloxone to heroin users.
    Darke S; Hall W
    Addiction; 1997 Sep; 92(9):1195-9. PubMed ID: 9374020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
    McDonald R; Campbell ND; Strang J
    Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
    Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
    Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription naloxone: a novel approach to heroin overdose prevention.
    Sporer KA; Kral AH
    Ann Emerg Med; 2007 Feb; 49(2):172-7. PubMed ID: 17141138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes.
    Williams AV; Marsden J; Strang J
    Addiction; 2014 Feb; 109(2):250-9. PubMed ID: 24103087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
    Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
    J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.
    Seal KH; Downing M; Kral AH; Singleton-Banks S; Hammond JP; Lorvick J; Ciccarone D; Edlin BR
    J Urban Health; 2003 Jun; 80(2):291-301. PubMed ID: 12791805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.
    Parmar MK; Strang J; Choo L; Meade AM; Bird SM
    Addiction; 2017 Mar; 112(3):502-515. PubMed ID: 27776382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths.
    Strang J
    Addiction; 2015 Jul; 110 Suppl 2():27-35. PubMed ID: 26042565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport.
    Vilke GM; Sloane C; Smith AM; Chan TC
    Acad Emerg Med; 2003 Aug; 10(8):893-6. PubMed ID: 12896894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency naloxone for heroin overdose: naloxone is not the only opioid antagonist.
    Brewer C
    BMJ; 2006 Oct; 333(7571):754-5. PubMed ID: 17023477
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.
    Maxwell S; Bigg D; Stanczykiewicz K; Carlberg-Racich S
    J Addict Dis; 2006; 25(3):89-96. PubMed ID: 16956873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone?
    Vilke GM; Buchanan J; Dunford JV; Chan TC
    Prehosp Emerg Care; 1999; 3(3):183-6. PubMed ID: 10424852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catch and release: evaluating the safety of non-fatal heroin overdose management in the out-of-hospital environment.
    Stam NC; Pilgrim JL; Drummer OH; Smith K; Gerostamoulos D
    Clin Toxicol (Phila); 2018 Nov; 56(11):1135-1142. PubMed ID: 29873588
    [No Abstract]   [Full Text] [Related]  

  • 18. Wasted, overdosed, or beyond saving--to act or not to act? Heroin users' views, assessments, and responses to witnessed overdoses in Malmö, Sweden.
    Richert T
    Int J Drug Policy; 2015 Jan; 26(1):92-9. PubMed ID: 25130869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.
    Kerr D; Dietze P; Kelly AM; Jolley D
    J Urban Health; 2008 May; 85(3):352-60. PubMed ID: 18347990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.